Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Angina Pectoris/MI
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Angina Pectoris/MI
    Certain Biomarkers Have Limitations in Predicting Cardiovascular Events - (DGNews)
    Routine early angioplasty after fibrinolysis for acute myocardial infarction - (N Engl J Med)
    Some Stroke Survivors' Function Slowly Declines Over Time - (DGNews)
    Migraine With Aura Frequency Plays a Role in Risk of Stroke, MI - (DGNews)
    TopAbstracts in Angina Pectoris/MI 06/24/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Angina Pectoris/MI
      Keys to Successful Outcomes from Anticoagulant and Antiplatelet Therapy: Addressing Medication Therapy Management Issues
      Cardiovascular Series: Guidelines for Anticoagulant and Antiplatelet Therapy in the Prevention and Treatment of Acute Coronary Syndrome: Incorporation into Clinical Practice
      Translating Evidence-Based Guidelines into Clinical Practice in the Management of Acute Coronary Syndrome
      Advancing the Standard of Care: Cardiovascular and Neurovascular Emergencies
      Anti-inflammatory and Anti-atherogenic Effects of Insulin

      Webcasts/CME archive

       Recent cases - Angina Pectoris/MI
        Giant Right Coronary Artery Aneurysm: Case Report and Literature Review
        Acute Myocardial Infarction and Pulmonary Embolism in a Young Man with Pernicious Anemia-Induced Severe Hyperhomocysteinemia
        Ultrasound In Evaluation of Post-Interventional Femoral Vein Obstruction: A Case Report
        Menstruation Angina: A Case Report
        Spontaneous Left Main Coronary Artery Dissection Complicated by Pseudoaneurysm Formation in Pregnancy: Role of CT Coronary Angiography

        Cases archive
          




        my personal edition > angina pectoris/mi > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Defibrillators Fight Long-term Post-Myocardial Infarction Mortality Risk: Presented at NASPE

        By Peggy Peck

        WASHINGTON, DC -- May 20, 2003 -- Implantable cardioverter-defibrillators (ICDs) can help reduce the risk of mortality and sudden death after a myocardial infarction (MI).

        The total risk for mortality and sudden death increases over time -- for as long as 15 years post-MI.

        These findings, from a new analysis of data collected by the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II), were presented here on May 16th at the 24th Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology.

        David J. Wilber, MD, a George M. Eisenberg Professor of Cardiovascular Sciences Medicine, Loyola University Health System, in Maywood, Illinois, noted that, based on the MADIT-II trial (1997-2001), "good evidence-based medicine supports the aggressive use of prophylactic [ICDs] in the very late phase of MI-associated ejection fractions under 30%."

        In this analysis of MADIT-II data, Dr. Wilber and his colleagues examined the time-dependence of mortality risk and ICD benefit in MADIT-II patients. Time from last MI was unavailable in 73 of the 1,232 participants, but the remaining 1,159 patients were enrolled at least 1 month after MI (mean 81 months).

        They randomised 699 patients to an ICD and 460 to a control group that received conventional best medical care. Additional therapy included angiotensin-converting enzyme (ACE)-inhibitor therapy in 72% of patients, beta blockers in 71%, and at least one revascularisation procedure in 77%.

        Overall, after a mean follow-up of 20 months, mortality was 19.8% with the control group, and 14.2% with an ICD -- a 31% reduction in mortality.

        When the researchers examined mortality by time from last MI in both treatment groups and divided into quartiles, they found a trend toward increased mortality as a function of time from MI (P=0.11) in control patients.

        "This means the benefit from ICDs actually increases over time," said Dr. Wilber "It makes the case for implanting ICDs even if the MI is remote." The hazard ratio for overall mortality benefit (ICD:controls) in the shortest duration post MI quartile (1-17 months) was 1.08 (P=0.81), while the hazard ratio for the remaining three quartiles (>18 months) was 0.56 (P<0.001).

        Explaining the rationale for the new analysis, Dr. Wilber noted that earlier studies of MI survival, especially those conducted in the 1970s and 1980s, found the early mortality burden to be significant, but "advances in treatment have significantly altered that picture," he noted. "With early revascularisation and better pharmacological therapy, there have been significant improvements in the survival of MI patients with low ejection fractions." Those advances, he said, have changed the epidemiology of post MI risk.


        [Study title: Time-dependence of Mortality Risk and Defibrillator Benefit Following Myocardial Infarction: Lessons from the Multicenter Automatic Defibrillator Implantation Trial II. Abstract 130]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send